GlucoTrack (GCTK) Files Routine 8-K, Confirms Nasdaq Listing

Ticker: GCTK · Form: 8-K · Filed: Jan 11, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateJan 11, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulatory-filing, corporate-governance, nasdaq-listing

TL;DR

**GlucoTrack (GCTK) filed a standard 8-K, confirming its Nasdaq listing and regulatory compliance.**

AI Summary

GlucoTrack, Inc. (GCTK) filed an 8-K on January 11, 2024, primarily to disclose its current report status and confirm its registration on the Nasdaq Capital Market under the trading symbol GCTK. This filing, while routine, is important for investors as it reaffirms the company's compliance with SEC regulations and its continued listing on a major exchange, which is crucial for liquidity and investor confidence. It signals that the company is maintaining its public reporting obligations.

Why It Matters

This filing confirms GlucoTrack's ongoing compliance with SEC reporting requirements and its listing on the Nasdaq Capital Market, which is fundamental for investor access and market credibility.

Risk Assessment

Risk Level: low — This is a routine administrative filing with no new material financial or operational information that would introduce significant risk.

Analyst Insight

Investors should note this filing as a confirmation of ongoing regulatory compliance and market listing, but it contains no new material information to prompt immediate action. It's a routine update.

Key Players & Entities

FAQ

What is the purpose of GlucoTrack, Inc.'s 8-K filing dated January 11, 2024?

The 8-K filing by GlucoTrack, Inc. on January 11, 2024, serves as a current report to the SEC, primarily disclosing Regulation FD information and confirming its registration under the Securities Exchange Act of 1934, specifically its common stock trading on the Nasdaq Capital Market under the symbol GCTK.

On which stock exchange is GlucoTrack, Inc.'s common stock registered?

GlucoTrack, Inc.'s common stock is registered on the Nasdaq Capital Market, as stated in the filing under 'Name of each exchange on which registered'.

What is the trading symbol for GlucoTrack, Inc. common stock?

The trading symbol for GlucoTrack, Inc. common stock is GCTK, as indicated in the 'Trading Symbol(s)' section of the filing.

What is the business address of GlucoTrack, Inc. as per the filing?

According to the filing, the business address of GlucoTrack, Inc. is 301 Rte 17 North, Ste. 800, Rutherford, NJ 07070.

What was the former name of GlucoTrack, Inc. and when did the name change occur?

The former name of GlucoTrack, Inc. was Integrity Applications, Inc., and the date of the name change was December 3, 2010, as per the 'FORMER COMPANY' section of the filing.

Filing Stats: 643 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2024-01-11 17:22:22

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 11, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing